At the center of this inflammatory-resistance interface lies the transcription factor NF-κB that is typically activated by inflammatory cytokines, prostaglandins, and stress mediators present in the tumor microenvironment, which in turn promotes the expression and activity of key MRPs [4,195]. The gene discussed is NFKB1; the disease is neoplasm.